Rapid Development Through Phase I CTM
From Development - Timing
Ascendia works with discovery-stage pharmaceutical companies to provide lab-scale formulations suitable for pre-clinical testing. We conduct pre-formulation assessments, bioavailability modeling, and formulation approach comparisons. We provide trial formulations suitable for animal studies, toxicology studies, and cGMP clinical trial materials for Phase I studies. At Ascendia, our core business is to develop practical, customized product formulations for poorly water soluble drugs. We offer rapid and cost-effective formulation technology screening services through the utilization of our multiple nano-particle technology platforms.
-
Most popular related searches
Servcies Overview
By working with Ascendia, our clients can quickly determine the feasibility of multiple technical approaches in parallel, thus improving the probability of formulation success and reducing the time and cost to make critical early-stage formulation decisions. Ascendia provides both the development and testing services – creating formulation solutions with enhanced biopharmaceutical properties suitable for clinical scale-up.
By working with Ascendia, our clients can quickly determine the feasibility of multiple technical approaches in parallel, thus improving the probability of formulation success and reducing the time and cost to make critical early-stage formulation decisions. Ascendia provides both the development and testing services – creating formulation solutions with enhanced biopharmaceutical properties suitable for clinical scale-up.
Customer reviews
No reviews were found for Rapid Development Through Phase I CTM. Be the first to review!